The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Applied DNA Sciences Inc

Nasdaq: APDN
Last

(U.S.) $2.94

Today's change+0.07 +2.44%
Updated May 24 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Applied DNA Sciences Inc

Nasdaq: APDN
Last

(U.S.) $2.94

Today's change+0.07 +2.44%
Updated May 24 4:00 PM -4GMT. Delayed by at least 15 minutes.

Applied DNA Sciences Inc crosses above 20-day moving average

Applied DNA Sciences Inc closed up sharply Tuesday, rallying (U.S.)$0.07 or 2.44% to (U.S.)$2.94 and crossing above its 20-day moving average. Over the last five days, shares have gained 8.09%, but are down 9.26% for the last year to date. Shares have outperformed the S&P 500 by 17.65% during the last year.

Key company metrics

  • Open(U.S.) $2.86
  • Previous close(U.S.) $2.87
  • High(U.S.) $2.95
  • Low(U.S.) $2.82
  • Bid / Ask(U.S.) $2.69 / (U.S.) $3.46
  • YTD % change-9.26%
  • Volume42,832
  • Average volume (10-day)119,981
  • Average volume (1-month)81,343
  • Average volume (3-month)99,890
  • 52-week range(U.S.) $2.35 to (U.S.) $9.70
  • Beta0.90
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.37
Updated May 24 4:00 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX0.24%Sector:Basic MaterialsIndustry:Chemicals - Specialty

Latest Company News

    No News Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue1142
Total other revenue--------
Total revenue1142
Gross profit--------
Total cost of revenue--------
Total operating expense4444
Selling / general / administrative3444
Research & development1010
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-3-30-2
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-3-30-2
Income after tax-3-30-2
Income tax, total0--00
Net income-3-30-2
Total adjustments to net income--------
Net income before extra. items-3-30-2
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3-30-2
Inc. avail. to common incl. extra. items-3-30-2
Diluted net income-3-30-2
Dilution adjustment--------
Diluted weighted average shares24232221
Diluted EPS excluding extraordinary itemsvalue per share-0.14-0.13-0.02-0.08
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.14-0.13-0.02-0.08